EP3979789A4 - Behandlung von saprolegnia - Google Patents

Behandlung von saprolegnia Download PDF

Info

Publication number
EP3979789A4
EP3979789A4 EP20818734.4A EP20818734A EP3979789A4 EP 3979789 A4 EP3979789 A4 EP 3979789A4 EP 20818734 A EP20818734 A EP 20818734A EP 3979789 A4 EP3979789 A4 EP 3979789A4
Authority
EP
European Patent Office
Prior art keywords
saprolegniasis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20818734.4A
Other languages
English (en)
French (fr)
Other versions
EP3979789A1 (de
Inventor
Vaibhav Srivastava
Sanjiv Kumar
Vincent Bulone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP3979789A1 publication Critical patent/EP3979789A1/de
Publication of EP3979789A4 publication Critical patent/EP3979789A4/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K61/00Culture of aquatic animals
    • A01K61/10Culture of aquatic animals of fish
    • A01K61/13Prevention or treatment of fish diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP20818734.4A 2019-06-05 2020-05-07 Behandlung von saprolegnia Pending EP3979789A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1950670 2019-06-05
PCT/SE2020/050468 WO2020246927A1 (en) 2019-06-05 2020-05-07 Treatment of saprolegniasis

Publications (2)

Publication Number Publication Date
EP3979789A1 EP3979789A1 (de) 2022-04-13
EP3979789A4 true EP3979789A4 (de) 2022-08-10

Family

ID=73652039

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20818734.4A Pending EP3979789A4 (de) 2019-06-05 2020-05-07 Behandlung von saprolegnia

Country Status (4)

Country Link
EP (1) EP3979789A4 (de)
CN (1) CN114007414A (de)
CA (1) CA3142601A1 (de)
WO (1) WO2020246927A1 (de)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109198303A (zh) * 2018-11-02 2019-01-15 临沂大学 一种能防治泥鳅水霉病的饲料及饲喂装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100782500B1 (ko) * 2006-05-22 2007-12-05 주식회사 바이넥스 천연 식물 추출물을 이용한 수생곰팡이 억제제
EP1982715A1 (de) * 2007-04-20 2008-10-22 Bayer CropScience AG Verwendung von Fungiziden zur Behandlung von Fischmykosen
JP2014519316A (ja) * 2011-04-29 2014-08-14 オーバーン ユニヴァーシティ 水生動物の感染の治療および予防に使用するためのバチルス菌
EP3402525A1 (de) * 2016-01-12 2018-11-21 Benchmark Animal Health Limited Behandlung von chitinhaltigen mikroorganismen
CN105767593A (zh) * 2016-03-10 2016-07-20 广州聚注专利研发有限公司 一种含植物提取组合物的鱿鱼膏及其制备方法
CN107372342A (zh) * 2017-08-30 2017-11-24 开县泰旭农业综合开发有限公司 一种娃娃鱼养殖过程中的疾病防治方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109198303A (zh) * 2018-11-02 2019-01-15 临沂大学 一种能防治泥鳅水霉病的饲料及饲喂装置

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KUMAR SANJIV ET AL: "Identification of Growth Inhibitors of the Fish Pathogen Saprolegnia parasitica Using in silico Subtractive Proteomics, Computational Modeling, and Biochemical Validation", FRONTIERS IN MICROBIOLOGY, vol. 11, 1 January 2020 (2020-01-01), pages 571093, XP055917909, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596660/pdf/fmicb-11-571093.pdf> DOI: 10.3389/fmicb.2020.571093 *
See also references of WO2020246927A1 *

Also Published As

Publication number Publication date
CA3142601A1 (en) 2020-12-10
CN114007414A (zh) 2022-02-01
EP3979789A1 (de) 2022-04-13
WO2020246927A1 (en) 2020-12-10

Similar Documents

Publication Publication Date Title
EP3426250A4 (de) Behandlungsverfahren
EP4031120A4 (de) Behandlung von syngap1-enzephalopathie
EP3893883A4 (de) Verfahren zur behandlung von depression
EP3937964A4 (de) Behandlung von onkogengesteuerten krebsarten
EP3735209A4 (de) Behandlung der progression von myopoie
EP3934632A4 (de) Esketamin zur behandlung von depression
EP3743057A4 (de) Behandlung von hörverlust
EP3752466A4 (de) Behandlung von cyanotoxinhaltigem wasser
EP4021858A4 (de) Behandlung von azolen
EP3941723A4 (de) Behandlungskammer
EP4081250A4 (de) Allergiebehandlung
EP3873528A4 (de) Behandlung von rasopathie
EP3774849A4 (de) Behandlung von entzündungen
GB201907305D0 (en) Treatment of conditions
EP3727376A4 (de) Verfahren zur behandlung von hypertriglyceridämie
EP3890780A4 (de) Verfahren zur behandlung
EP3833378A4 (de) Behandlung von warzen
EP3826825A4 (de) Behandlung von gegenständen
EP3884944A4 (de) Verwendung von chidamid
EP3573634A4 (de) Präparat zur behandlung von wunden
EP3979789A4 (de) Behandlung von saprolegnia
EP4034125A4 (de) Behandlung von erkrankungen im zusammenhang mit exzitotoxizität
EP4065573A4 (de) Verfahren zur behandlung
EP4025218A4 (de) Verfahren zur behandlung
AU2019903588A0 (en) Treatment of excitotoxicity-related conditions

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20211210

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

A4 Supplementary search report drawn up and despatched

Effective date: 20220707

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/635 20060101ALI20220701BHEP

Ipc: A61K 31/20 20060101ALI20220701BHEP

Ipc: A61K 31/10 20060101ALI20220701BHEP

Ipc: A61K 31/42 20060101ALI20220701BHEP

Ipc: A61K 31/194 20060101ALI20220701BHEP

Ipc: A61K 31/165 20060101ALI20220701BHEP

Ipc: A61K 31/16 20060101ALI20220701BHEP

Ipc: A01K 61/13 20170101AFI20220701BHEP

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20240613

17Q First examination report despatched

Effective date: 20240701